Quantcast

Posts related to ‘Parkinson's disease’

Stock Split Image

Chelsea Therapeutics Rally — Speculation or Desperation?

Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is rallying on Wednesday after a report in Seeking Alpha called its Northera, a treatment for symptomatic neurogenic hypotension in Parkinson's patients, a shoe-in for approval, ...
Read Full Story »

ACADIA Rises Exponentially on Phase III Parkinson’s Disease Trial

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is proving to be the big winner of the day. In fact, it may be the winner of the month on any percentage gain in ...
Read Full Story »